Your browser doesn't support javascript.
loading
Challenges in the clinical assessment of novel tuberculosis drugs.
Dooley, Kelly E; Phillips, Patrick P J; Nahid, Payam; Hoelscher, Michael.
Afiliação
  • Dooley KE; Divisions of Clinical Pharmacology & Infectious Diseases, Center for Tuberculosis Research, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Osler 527, Baltimore, MD, 2187, USA. Electronic address: kdooley1@jhmi.edu.
  • Phillips PP; MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC1B 6NH, UK. Electronic address: Patrick.phillips@ucl.ac.uk.
  • Nahid P; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, at San Francisco General Hospital, 1001 Potrero Ave., 5K1, San Francisco, CA, USA. Electronic address: pnahid@ucsf.edu.
  • Hoelscher M; Division of Infectious Diseases and Tropical Medicine, Medical Centre of the University of Munich (LMU), Leopoldstrasse 5, 80802 Munich, Germany; German Centre for Infection Research (DZIF), Leopoldstrasse 5, 80802 Munich, Germany; German Centre for Infection Research, Leopoldstrasse 5, 80802 Munich
Adv Drug Deliv Rev ; 102: 116-22, 2016 07 01.
Article em En | MEDLINE | ID: mdl-26827911

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Tuberculose / Antituberculosos Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Tuberculose / Antituberculosos Limite: Animals / Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2016 Tipo de documento: Article